Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03951415 |
|---|---|
| Brief Title: | Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer (DOMEC) |
| First Submitted : | April 30, 2019 |
| First Submitted that Met QC Criteria : | May 14, 2019 |
| First Posted : | May 15, 2019 |
| Last Update Submitted that Met QC Criteria : | March 30, 2021 |
| Last Update Posted : | April 1, 2021 |